Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,788 GBX | +0.45% | +3.01% | +22.78% |
May. 08 | Gsk plc Announces Board Committee Changes | CI |
May. 08 | GSK : Receives a Buy rating from Bernstein | ZD |
Sales 2024 * | 31.61B 39.64B | Sales 2025 * | 33.56B 42.08B | Capitalization | 72.61B 91.05B |
---|---|---|---|---|---|
Net income 2024 * | 5.59B 7B | Net income 2025 * | 6.47B 8.12B | EV / Sales 2024 * | 2.69 x |
Net Debt 2024 * | 12.3B 15.43B | Net Debt 2025 * | 9.1B 11.41B | EV / Sales 2025 * | 2.44 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.3
x | Employees | 70,212 |
Yield 2024 * |
3.42% | Yield 2025 * |
3.55% | Free-Float | 94.38% |
Latest transcript on GSK plc
1 day | +0.39% | ||
1 week | +3.01% | ||
Current month | +6.43% | ||
1 month | +10.18% | ||
3 months | +7.26% | ||
6 months | +25.79% | ||
Current year | +22.78% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.17% | 11 M€ | +0.83% | - | |
3.15% | 0 M€ | +7.69% | - | |
2.51% | 0 M€ | +7.65% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1,780 | +0.39% | 3 904 033 |
24-05-08 | 1,774 | +0.71% | 6,684,171 |
24-05-07 | 1,761 | +1.59% | 14,302,770 |
24-05-03 | 1,734 | +0.29% | 4,237,170 |
24-05-02 | 1,728 | +1.38% | 6,275,228 |
Delayed Quote London S.E., May 09, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.78% | 90.86B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.34% | 239B | |
+6.68% | 204B | |
-9.08% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- GSK Stock